Prescription conditions for sotorasib

Sotorasib (Sotorasib) is a targeted therapy drug, and its use needs to meet certain medication conditions to ensure patient safety and optimal therapeutic effects. The following are generally applicable medication conditions:

First of all, sotorasiib is mainly used to treat patients with advanced non-small cell lung cancer (NSCLC) who carry the KRAS G12C mutation. Therefore, before using sotorasiib, genetic testing is usually required to confirm that the patient's tumor indeed carries this specific genetic mutation. This helps personalize treatment and make drugs more targeted.

Secondly, patients should carefully inform their doctors about their allergy history, existing drug use, and other potential health problems before receiving sotorasiib treatment. This helps doctors comprehensively assess the patient's physical condition and ensure the safe use of drugs.

In addition, because sotorasiib may interact with other medications, doctors need to know what medications the patient is currently taking to avoid possible drug interactions. In some cases, dosage or treatment regimen adjustments of other medications may be necessary.

During treatment, patients usually require regular monitoring and follow-up, including imaging examinations and laboratory tests, to evaluate the efficacy of the drug and the patient's overall health. This helps to detect potential adverse reactions or changes in condition in a timely manner and take appropriate measures.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.